Business Context and Reporting Period
This Form 6-K filing by Ambev S.A. covers the month of February 2026, with the report signed on March 10, 2026. The filing is submitted pursuant to Rule 13a-16 of the Securities Exchange Act of 1934 and complies with Article 11 of CVM Instruction # 44/2021. The document specifically details transactions involving the company's own securities (treasury shares) and derivatives.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. Instead, it reports on treasury share activity:
- Initial Treasury Balance: 145,113,436 Common Shares.
- Final Treasury Balance: 144,870,526 Common Shares.
- Total Shares Delivered: 242,910 Common Shares.
- Total Transaction Volume: R$ 4,003,081.67.
Material Changes
The material change reported is a reduction in the company's treasury share holdings due to the delivery of restricted shares. Three specific transactions occurred in February 2026:
- February 2: Delivery of 1,942 shares at R$ 13.28 per share (Volume: R$ 25,789.76).
- February 13: Delivery of 220,383 shares at R$ 16.52 per share (Volume: R$ 3,640,727.16).
- February 16: Delivery of 20,585 shares at R$ 16.35 per share (Volume: R$ 336,564.75).
The filing text does not provide a prior comparable period for these specific treasury transactions to establish a trend.
Guidance, Outlook, and Risks
This filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document is strictly a regulatory disclosure of insider/issuer transactions regarding restricted share deliveries.
Investor Verification Checklist
- Verify the impact of the 242,910 shares delivered on the company's total outstanding share count and earnings per share (EPS) calculations.
- Confirm the nature of the "restricted shares" delivered to understand if they relate to employee compensation plans or other specific agreements.
- Review the price variance between the February 2 transaction (R$ 13.28) and subsequent transactions (R$ 16.52/R$ 16.35) to assess market conditions or specific grant terms.
- Note that this filing does not contain quarterly or annual financial results; investors should refer to the Form 20-F for comprehensive financial data.